RNA-sequencing Analysis of Hybrid Females Reveals a Dominance of Expression of Alleles From Outcrossing Species Over Those From Selfing Species

对杂交雌性的RNA测序分析表明,异交物种的等位基因表达比自交物种的等位基因表达更具显性。

阅读:2

Abstract

The sister species Caenorhabditis briggsae and Caenorhabditis nigoni are the first Caenorhabditis nematode pair known to produce viable F1 hybrids, making them an ideal model for speciation study. Male F1 hybrids are lethal or sterile depending on the parent of origin, while F1 females, though viable, exhibit distinct phenotypes in fecundity and viability. Besides, both female hybrids could mate with C. nigoni males to produce viable progeny but experience hybrid breakdown when crossed with C. briggsae males. The molecular mechanisms driving these phenotype variations in F1 females remain unknown. Here, we analyzed the transcriptomes of F1 female hybrids from both crossing directions to examine whether a parent-specific haplotype dominates gene expression in the hybrids and to explore the mechanisms underlying the distinct phenotypes. We showed that in female hybrids from both directions, the C. nigoni haplotype was more abundantly expressed and maintained the parental expression patterns better than that of C. briggsae. We also observed an upregulation of female-biased genes in the C. nigoni haplotype of F1 females, which may explain their compatibility with C. nigoni males for producing viable progeny, suggesting a haplotype-specific influence on female reproductive traits. Our mitochondrial gene analysis suggested a nuclear-cytoplasmic incompatibility marked by cis-dominated expression patterns of mitochondrial genes, which may contribute to the reduced viability in F1 females. This research provides insights into the expression pattern of interspecies F1 female hybrids and the mechanisms underlying nonlethal hybrid incompatibility defects.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。